• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

DAACAAHCLFR details
Primary information
ID antitb_1345,
Name9693108
N-Terminal modificationTenecin 1 fragment 17-27
C-Terminal ModificationDAACAAHCLFR
Chemical ModificationFree
Linear/CyclicAmidation
LengthInternal disulphide bond
ChiralityCyclic
Nature11
SpeciesNatural
StrainLarvae of tenebrio molitor(beetle)
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis ATCC 608
Cell LineMIC = >100 μg/ml
Inhibition Concentrationin vitro
Sequence1998
CytotoxicityHuman erythrocyte
In vivo ModelNA
Lethal DoseNone
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyMembrane disruption as reported by membrane leaky assay
Other activitiesNA
PMIDNA
Year of PublicationNone
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1346,
Name9693108
N-Terminal modificationTenecin 1 fragment 16-32
C-Terminal ModificationDAACAAHCLFR
Chemical ModificationFree
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature11
SpeciesNatural
StrainLarvae of tenebrio molitor(beetle)
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis ATCC 609
Cell LineMIC = >100 μg/ml
Inhibition Concentrationin vitro
Sequence1998
CytotoxicityHuman erythrocyte
In vivo ModelNA
Lethal DoseNone
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyMembrane disruption as reported by membrane leaky assay
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),